NCT07347392Enrolling by invitation
The Role of Radiotherapy for the Management of Non-melanoma Skin Cancer in Denmark.
The Role of Radiotherapy for the Management of Non-melanoma Skin Cancer in Denmark
Source: ClinicalTrials.gov · Last updated 16 Jan 2026
Brief summary (registry, in English)
The goal of this observational study is to learn about the long-term effects of radiotherapy for people who were treated for non-melanoma skin cancer (NMSC) in the head and neck area. The study focuses on adults who finished radiotherapy at least two years ago. The main questions we aim to answer are: How satisfied are participants with the cosmetic result of their treatment? What skin changes do healthcare professionals observe at the treated area? How many participants have experienced a recurrence or developed a new skin cancer, since treatment? Participants will be invited to: Attend one extra hospital visit at least two years after they finished radiotherapy Answer a short questionnaire about their cosmetic satisfaction Have their skin examined, including photos and dermatoscopy The results may help improve future treatment guidelines for people with non-melanoma skin cancer.professional, and any local recurrences will be identified through national health registries. This nationwide study (DOSCA-2) will provide real-world data to help guide future treatment recommendations for NMSC.
- Status (registry)
- Enrolling by invitation
- Study type
- Observational
- Enrollment
- 2900 (estimated)
- First submitted
- 15 Dec 2025
- Start date
- 15 Dec 2025
- Primary completion date
- 1 Sept 2029
- Lead sponsor
- University of Aarhus
- Diseases
- Melanoma
- NCT number
- NCT07347392
What you commit to
- Study type: Observational
- Planned participants: 2900
- From 15 Dec 2025 to the primary completion date, 1 Sept 2029
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Individuals who are incapable of giving informed consent
Who the study is looking for
- Adults aged 18 years or older
- Received primary radiotherapy for malignant non-melanoma skin cancer (basal cell carcinoma or cutaneous squamous cell carcinoma) of the head and neck region between 2020 and 2024
- Able to understand and communicate in written and spoken Danish or English
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Aarhus University Hospital Coordinator of this site? Confirm its status | Aarhus N | Denmark | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.